KIDNEY CANCER METASTATIC
Clinical trials for KIDNEY CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new KIDNEY CANCER METASTATIC trials appear
Sign up with your email to follow new studies for KIDNEY CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted drug shows promise for Hard-to-Treat kidney cancer
Disease control Recruiting nowThis study tests a daily pill called olaparib in people with advanced kidney cancer that has certain gene mutations (like BAP-1 or BRCA). The goal is to see if the drug can shrink tumors or keep them stable for at least six months. About 20 adults who have already tried other tre…
Matched conditions: KIDNEY CANCER METASTATIC
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 16, 2026 23:33 UTC
-
Radiation boost may extend life in kidney cancer that has spread
Disease control Recruiting nowThis study tests whether adding precise, high-dose radiation (SBRT) to standard drug therapy can help people with kidney cancer that has spread to up to 5 spots live longer without the cancer growing. About 252 adults with kidney cancer will be randomly assigned to receive either…
Matched conditions: KIDNEY CANCER METASTATIC
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New hope for advanced kidney cancer: first human trial of NEO-811 begins
Disease control Recruiting nowThis early-stage study tests a new drug called NEO-811 in people with advanced clear cell kidney cancer that cannot be removed by surgery. About 30 participants who have tried other treatments or cannot take them will receive the drug to see if it is safe and what dose works best…
Matched conditions: KIDNEY CANCER METASTATIC
Phase: PHASE1 • Sponsor: Neomorph, Inc • Aim: Disease control
Last updated May 11, 2026 20:41 UTC